/PRNewswire/ – BioAmber Inc., a leader in renewable materials, today announced that George F.J. Gosbee is joining its board of directors, effective today. Mr. Gosbee will replace Henry “Pete” Linsert, Jr. who resigned his board seat for personal reasons, effective today.
George Gosbee brings extensive capital markets experience and deep knowledge of the oil and gas industry. His profile is complementary to existing board members and he will provide insight and advice on navigating capital markets, positioning the company vs. fossil fuels, approaching new investors and raising the Company’s visibility. Mr. Gosbee has been elected a Class II director, to hold office until the 2018 annual meeting of stockholders. Mr. Gosbee will serve on the Nominating and Corporate Governance Committee and the Compensation Committee.
“On behalf of the entire board and management team, I would like to thank Pete for his valuable insight and contributions over the past 20 months,” said Ray Land, Chairman of the board. “Pete’s experience and wisdom will be missed, but we are thrilled to have someone of George’s caliber and financial background joining the board.”
About George F.J. Gosbee
Mr. Gosbee’s career spans over 20 years in corporate finance, investment banking, global capital markets and advisory. Prior to founding AltaCorp Capital in 2010, Mr. Gosbee was Chairman, President and CEO of Tristone Capital Global Inc., a global energy investment firm which he founded. Tristone became the largest global independent energy advisory firm and was acquired by an international bank in 2009. His current firm, AltaCorp Capital, is an advisory firm that is partnered with Alberta Treasury Branch (ATB Financial), a wholly owned subsidiary of the Government of Alberta.
Mr. Gosbee is a former Governor of the National Hockey League (NHL). He led a group to purchase the Arizona Coyotes and restructure the Club. Currently he is an Alternate Governor on the NHL Board of Governors and Co-owner of the Arizona Coyotes.
Mr. Gosbee was the Vice Chairman of Alberta Investment Management Co (AIMCo) and was called on to assist in the creation of the crown corporation. He spent 8 years as the Vice Chair of AIMCo, which is a $90 billion institutional investment fund, and currently is a Director. Mr. Gosbee is a former Director of the TMX Group and a former Board Member of Chrysler Group LLC in Detroit, where he served on behalf of both the Canadian Federal and Provincial (Ontario) governments to oversee their collective investment in the company and assist in the restructuring.
Big Pharma has long seen the potential for AI and machine learning to accelerate drug development. But Novo Nordisk is going a step further by channeling $200 million toward the creation of a computer that will outrun anything in existence.
Current methods for diagnosing Alzheimer’s disease rely on a complex combination of self- and caregiver-reported symptoms, a physical examination and either a PET scan or a spinal tap to look for evidence of amyloid plaque build-ups in the brain. But a new artificial intelligence-based method may make the diagnostic process a much more objective one.
There is lots of talk about diversity and inclusion in business, including in pharma and medtech. A new report by the Open Political Economy Network (OPEN), a think tank focusing on migration and diversity, released its “Minority Businesses Matter: Europe” report highlighting the successes and challenges of ethnic minority-owned businesses in Europe.